Genmab | GEN - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Almirall EUR 2.76B 472.53M 2025-12
Amarin USD 290M 51M 2025-12
Amgen USD 189.89B 13.64B 2026-03
argenx SE USD 44.38B 7.45B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Bayer EUR 38.69B 2.33B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Demant DKK 46.01B 10.48B 2025-12
Exelixis USD 10.89B 857M 2026-03
Fresenius Medical Care EUR 11.32B 642.58M 2026-03
Genmab DKK 20.48B 1.02B 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
GN Store Nord DKK 15.22B 890.39M 2026-03
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Insmed USD 35.3B 1.82B 2026-03
Lakefront Biotherapeutics EUR 1.73B 119.93M 2026-03
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 46.78B 6.52B 2026-03
Novartis USD 307.76B 15.54B 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
UCB EUR 46.41B 13.94B 2025-12